2nd GPCR-Targeted Drug Discovery Summit (description)


Address:1 Avenue de Lafayette Boston, Massachusetts, United States of America 02111
Phone:+1 617 455 4188
Event dates:2/21/2023 - 2/23/2023 (This event has already taken place)
Event web site:
findCE GPA: This event is not yet rated. Click here to view a sample report card
Click here to rate 2nd GPCR-Targeted Drug Discovery Summit


Topics to be Covered:

  • Graeme Milligan, Professor, University of Glasgow
  • Bryan Roth, Professor of Pharmacology, UNC School of Medicine
  • Jeff Finer, Chief Executive Officer, Septerna
  • Kate Lansu, Senior Scientist, Eli Lilly & Company
  • Laurent Sabbagh, Head of Biology, DOMAIN Therapeutics
  • Science, Health & Medicine
  • Pharmaceuticals
Organizer phone:+1 617 455 4188
Offering type:Conference
Specialty:Data not provided
Event frequency:Never
First Meeting:
Total events:
Est. attendance:
Target audience:Any
Other target audiences:
Host Sponsor:Hanson Wade
Est. # of exhibitors:
Currency:US Dollars
Language:Data not provided
CE Credits:
Organizer URL


Unlocking the Next Wave of Clinically Relevant GPCR Targets

Returning for the 2nd year, the GPCR-Targeted Drug Discovery Summit is the only industry-led meeting of its kind dedicated to congregating the most forward thinking biotechs, established large pharma, and key academic opinion leaders committed to discovering and validating the next wave of GPCR targets across a breadth of indications.

- Welcoming a whole host of exciting new GPCR-focused biotechs onto the agenda, with presentations from Septerna, Tectonic, DJS Antibodies, OKYO Pharma, and On Target Therapeutics

- Increased emphasis on allosteric modulation with 5 talks dedicated to highlighting novel methods of integrating this new ‘modality’ and the potential it holds as an alternative to agnostic and antagonistic targeting

- A brand-new workshop day featuring 3 workshops; workshop A on specific, lesser explored GPCR receptors (adhesion and chemokine) led by 2 key academic leaders, workshop B on allosteric modulation with 3 expert leaders, and workshop C, a deep dive into what venture capitalists are looking for in the GPCR space right now

… as well as covering the most pressing challenges in GPCR-target identification with integration of novel platforms, target validation with improvements being made in in-vitro assay kits, and predictive modelling enhancements made by machine learning and computational technologies.

The 2nd GPCR-Targeted Drug Discovery Summit will equip your team with the knowhow to tackle hurdles in the orphan drug space, elevate understanding of opportunity in dark targets, bias signalling, and the various modalities currently being pursued as novel GPCR drug candidates.

February 21-23, 2023

Boston, MA



Time: 8:00 AM - 5:00 PM

Registration Fee Details:

Drug Developers (Earlybird rates & workshops available) USD 3199.00
Academic (Earlybird rates & workshops available) USD 2799.00
Service Providers (Earlybird rates & workshops available) USD 3799.00

Other items that tuition includes:

Travel and hotel arrangements:

Contact Person:2nd GPCR-Targeted Drug Discovery Summit
Organizer State/Province: (Outside US)
Organizer CountryData not provided
Organizer Phone+1 617 455 4188
Structural makeupData not provided
Host Sponsor; Other SponsorsHanson Wade
Event Site/VenueHyatt Regency Boston
Event sold out?No
Multiple locations or dates?No
Statistics available for most recent event held in:NA
Average number in event attendance of:
Number in attendance of:
Target BoundariesInternational
Is Registration contact information the same as Organizer Contact above?Yes
Web Page
Can one register for your CE on your web site?NA
Can registration be made by snail (regular) mail?Yes
Online housing reservations: 
Do you have additional written or AV materials for sale?No
If so, are they available for non-attendees as well as those attending?NA
Is full tuition necessary to ensure registration?No
Will there be shuttle service available?NA
Additional notes:Brochure

Sign In/Sign Out
About Us
Contact Us